Today, we announced our Q2 2024 Financial Results and provided a corporate update. https://lnkd.in/eRZAcuMi
Lyra Therapeutics
Biotechnology Research
Watertown, Massachusetts 8,145 followers
Clinical-stage biotechnology company developing innovative therapies for the localized treatment of CRS
About us
Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities. Building on expertise in materials science, drug development and formulation, Lyra has developed proprietary technology that is designed to deliver medicines directly precisely and consistently to the affected tissue for sustained periods with a single administration. Our product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, in-office procedure and intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages for the treatment of CRS.
- Website
-
http://www.lyratx.com
External link for Lyra Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Watertown, Massachusetts
- Type
- Public Company
- Founded
- 2018
- Specialties
- Pharmaceuticals and Biotechnology
Locations
-
Primary
480 Arsenal St
Watertown, Massachusetts 02472, US
Employees at Lyra Therapeutics
Updates
-
📢 Cellino is #hiring! We have two incredible opportunities for new team members to join us in building an autonomous biomanufacturing platform to scale production of personalized regenerative medicines. Our team is seeking a driven and experienced Therapeutic Pipeline Associate and Product Manager in Advanced Biomanufacturing Technology. The Therapeutic Pipeline Associate will focus on developing frameworks for potential therapeutic programs, while the Product Manager will guide the development of Cellino’s advanced biomanufacturing technology. Both roles will play a critical part on the product team and report to our Co-Founder & Chief Product Officer, Marinna Madrid, PhD. 👋 Our team is located in #CambridgeMA and is at the forefront of personalized regenerative medicine! Apply now, or share this link: https://bit.ly/4bwSEwA 🚀 #GreaterBoston #BostonJobs #LifeSciences #Biotech #Biotechnology #Innovation #Autologous #AI #MachineLearning #RegenMed #PersonalizedMedicine #STEMCareers #YourCellsYourCure #CellinoBio
-
For anyone hiring biotech talent…it has been a difficult week at Lyra Therapeutics, having announced a restructuring that has resulted in having to say goodbye to 80+ valued colleagues after failing to meet our Phase 3 primary endpoint. These are talented and dedicated professionals. If you are hiring, please comment below or reach out privately. Resume book coming soon.
-
Today, we announced our Q1 2024 Financial Results and provided a corporate update. https://lnkd.in/eJW6NXF6
-
This #AdministrativeProfessionalsDay, we thank the hardworking admin professionals at Lyra and beyond who keep everything organized!
-
We are hiring! Are you looking for a great team working together to make a difference for patients? Check out our job openings and come help us change the treatment paradigm for #ChronicRhinosinusitis.
-
Today, we announced our Q4 and Full Year 2023 Financial Results and provided a corporate update.
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | Lyra Therapeutics, Inc.
investors.lyratherapeutics.com
-
On #InternationalWomensDay, we recognize all of the incredible women at Lyra. #IWD #IWD24
-
This #EmployeeAppreciationDay, we recognize the Lyra team’s hard work and dedication to improve the lives of people with #CRS. #ChronicRhinosinusitis
-
Yesterday we opened our new corporate headquarters, labs and manufacturing facility in Waltham, MA #chronicrhinosinusitis